• Spleen-Targeted Neoantigen mRNA Vaccine Drives ISG15+ CD8+ T

  2026-06-19

  Lin et al. present a spleen-targeted neoantigen mRNA vaccine (STNvac) that achieves potent antitumor immunity in hepatocellular carcinoma by inducing a distinct ISG15+ CD8+ T cell population and promoting tertiary lymphoid structure formation through GZMA-F2R signaling. This study outlines a mechanistic advance in personalized mRNA vaccine design for overcoming immune resistance in HCC, with clear implications for translational RNA therapeutics.

• Cy3-UTP: Advanced Fluorescent RNA Labeling for Live Imaging

  2026-06-19

  Cy3-UTP empowers researchers with high-brightness, photostable RNA labeling for state-of-the-art imaging and interaction studies. Its robust integration into in vitro workflows makes it indispensable for visualizing dynamic RNA processes and protein interactions in real time.

• Elevating CRC Biomarker Discovery: HyperScript III RT SuperM

  2026-06-18

  This thought-leadership article explores how advanced reverse transcription chemistry—exemplified by HyperScript™ III RT SuperMix for qPCR (with gDNA wiper)—enables precise, reproducible gene expression analysis for translational colorectal cancer (CRC) research. Integrating mechanistic insights from recent bile acid metabolism subtyping studies, it guides researchers in overcoming the technical and biological complexities of low-abundance biomarker detection. Anchored by strategic protocol parameters, competitive benchmarking, and an evidence-based outlook, the article demonstrates APExBIO’s leadership in supporting next-generation oncology and immunology workflows.

• Iron Stress Reprograms Enterocyte Metabolism and Inflammatio

  2026-06-18

  Navazesh and Ji’s 2025 study reveals how iron deficiency and excess distinctly rewire enterocyte metabolism and inflammation in a neonatal pig cell model. Using the iron chelator Deferiprone, the research uncovers dynamic metabolic, transcriptional, and inflammatory shifts, providing mechanistic insights critical for gut health studies and iron supplementation strategies.

• Mycophenolic Acid: Reliable Dehydrogenase Inhibitor for Immu

  2026-06-17

  This article addresses real-world challenges in immunometabolism and cell viability assays, demonstrating how Mycophenolic acid (SKU B1981) enables reproducible, sensitive, and cost-effective workflows. Scenario-driven Q&A blocks provide practical guidance for protocol optimization, data interpretation, and vendor selection, with evidence-backed recommendations tailored to biomedical researchers and laboratory scientists.

• Ceruletide: Molecular Insights for Pancreatic Function Resea

  2026-06-17

  Ceruletide (Caerulein) is a synthetic decapeptide used to model pancreatic fibrosis and study gastrointestinal physiology. It acts as a potent CCK receptor agonist, enabling reproducible investigation of digestive disorders and pancreatic function. Protocol precision and mechanistic clarity make Ceruletide a benchmark tool in translational research.

• X-Gal: Chromogenic Substrate for Blue-White Colony Screening

  2026-06-16

  X-Gal (5-bromo-4-chloro-indolyl-β-D-galactopyranoside) is a high-purity chromogenic substrate enabling reliable blue-white colony screening in molecular cloning workflows. It is hydrolyzed by β-galactosidase to yield a blue insoluble dye, facilitating rapid differentiation of recombinant clones. APExBIO’s X-Gal A2539 provides stable, reproducible results across research applications.

• Modeling Human SAN-Neural Maturation with PSC-Derived Assemb

  2026-06-16

  This study introduces a human in vitro model that integrates pluripotent stem cell-derived sinoatrial node (SAN) and cardiac plexus organoids to recapitulate neuro-cardiac interactions essential for pacemaker maturation. The platform enables mechanistic analysis of neuron-to-pacemaker signaling and reveals new molecular pathways involved in conduction and autonomic regulation.

• Plk1 Regulation of p31comet and Mitotic Checkpoint Disassemb

  2026-06-15

  This study elucidates how Polo-like kinase 1 (Plk1) regulates the function of p31comet in the disassembly of mitotic checkpoint complexes (MCC), revealing a phosphorylation-dependent inhibitory mechanism. The findings refine our understanding of mitotic progression control and offer valuable mechanistic insight for cell cycle and cancer research workflows.

• Phosphoproteomic Adaptation to Chronic Cabozantinib in RCC C

  2026-06-15

  This study applies quantitative phosphoproteomics to delineate how renal cell carcinoma (RCC) cells remodel signaling networks in response to acute versus chronic Cabozantinib (XL184) exposure. The findings reveal distinct timescale-dependent adaptations in phosphorylation and cell motility, providing a framework for mechanistic studies of kinase inhibitor responses.

• Chamber-Specific Induction of RV-like Cardiomyocytes from hP

  2026-06-14

  Saito et al. present a refined differentiation protocol enabling selective generation of right ventricular (RV)-like cardiomyocytes from human pluripotent stem cells (hPSCs). Their findings establish a practical basis for modeling RV-specific cardiac diseases in vitro by leveraging precise manipulation of early signaling cues during mesoderm induction.

• Indomethacin Sodium Trihydrate: COX Inhibition & Beyond

  2026-06-13

  Indomethacin Sodium Trihydrate is a nonselective cyclooxygenase inhibitor that also modulates Wnt/β-catenin signaling and GSK3β activity. Its robust solubility and validated efficacy empower inflammation assay workflows. This dossier clarifies its mechanisms, benchmarks, and best-use protocols for anti-inflammatory research.

• Go 6983: Pan-PKC Inhibitor for Cancer and Cell Fate Research

  2026-06-12

  Go 6983 is a potent pan-PKC inhibitor, enabling precise modulation of PKC isoforms in cancer progression and cell fate studies. Its nanomolar efficacy and selectivity make it a benchmark tool for dissecting PKC-dependent signaling pathways. APExBIO supplies Go 6983 for advanced research applications.

• Telmisartan: Applied Protocols for Cardiovascular Disease Re

  2026-06-12

  Telmisartan, a potent angiotensin II receptor antagonist, is transforming hypertension and cardiac hypertrophy research through precise pathway targeting and robust experimental workflows. Discover actionable protocols, troubleshooting insights, and how its integration with necroptosis signaling studies sets a new benchmark for cardiovascular disease research.

• Streptozotocin Models: Advancing Diabetic Neuropathy Discove

  2026-06-11

  Explore how Streptozotocin (STZ) enables translational researchers to model not only diabetes but also its neuroinflammatory complications, such as painful diabetic neuropathy (PDN). This article delivers mechanistic insight, practical protocol guidance, and strategic perspective, highlighting the integration of TBK1-driven microglia pyroptosis findings and positioning APExBIO’s STZ as an essential tool for precision diabetes research.

15118 records 1/1008 page Next 12345 下5页 Last page